Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
JCO Global Oncology
|
February 20, 2026
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML
Gojiri Mawalankar, Aarti Achrekar, Seema Biswas, et al.
Immunology and Cell Biology
|
September 28, 2021
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients
Prashant R Tembhare, Harshini Sriram, Gaurav Chatterjee, et al.
International Journal of Clinical Practice
|
June 10, 2022
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai
Arusha Shetty, Gaurav Chatterjee, Sweta Rajpal, et al.
The Lancet. Haematology
|
February 10, 2025
Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trial
Jorge E Cortes, Dong-Wook Kim, Tapan Saikia, et al.
Cancer Medicine
|
November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India
Sumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Cancer Medicine
|
October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment
Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
Indian Journal of Cancer
|
August 28, 2018
Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit
Navin Khattry, Siddhartha Laskar, Manju Sengar, et al.
Blood Cancer Journal
|
April 24, 2025
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study
Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain, et al.
The National Medical Journal of India
|
December 3, 2022
Cancer care continuum at a tertiary care centre in India during the Covid-19 pandemic and nationwide lockdown: Healthcare delivery through telemedicine
Anant Gokarn, Amit Joshi, Tabassum Wadasadawala, et al.
Blood Cell Therapy
|
December 9, 2024
Impact of the COVID-19 outbreak on the field of hematopoietic cell transplantation in the Asia-Pacific region: APBMT Activity Survey 2020/2021
Minako Iida, Aloysius Ho, Xiao Jun Huang, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
JCO Global Oncology
|
February 20, 2026
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML
Gojiri Mawalankar, Aarti Achrekar, Seema Biswas, et al.
Immunology and Cell Biology
|
September 28, 2021
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients
Prashant R Tembhare, Harshini Sriram, Gaurav Chatterjee, et al.
International Journal of Clinical Practice
|
June 10, 2022
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai
Arusha Shetty, Gaurav Chatterjee, Sweta Rajpal, et al.
The Lancet. Haematology
|
February 10, 2025
Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trial
Jorge E Cortes, Dong-Wook Kim, Tapan Saikia, et al.
Cancer Medicine
|
November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India
Sumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Cancer Medicine
|
October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment
Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
Indian Journal of Cancer
|
August 28, 2018
Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit
Navin Khattry, Siddhartha Laskar, Manju Sengar, et al.
Blood Cancer Journal
|
April 24, 2025
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study
Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain, et al.
The National Medical Journal of India
|
December 3, 2022
Cancer care continuum at a tertiary care centre in India during the Covid-19 pandemic and nationwide lockdown: Healthcare delivery through telemedicine
Anant Gokarn, Amit Joshi, Tabassum Wadasadawala, et al.
Blood Cell Therapy
|
December 9, 2024
Impact of the COVID-19 outbreak on the field of hematopoietic cell transplantation in the Asia-Pacific region: APBMT Activity Survey 2020/2021
Minako Iida, Aloysius Ho, Xiao Jun Huang, et al.
Page
of 12